Glaucoma News and Research

Latest Glaucoma News and Research

RetiPharma secures funding to develop new peptide drug for treating degenerative eye disorders

RetiPharma has secured funding from the Novo Nordisk Foundation’s BioInnovation Institute to develop a new drug for degenerative eye disorders.

From Novo Nordisk 15 Nov 2018

Chronic dry eye can slow reading rate and disrupt day to day tasks

Johns Hopkins researchers report that chronic dry eye, a condition in which natural tears fail to adequately lubricate the eyes, can slow reading rate and significantly disrupt day to day tasks that require visual concentration for long periods of time.

15 Nov 2018

KE Eye Centers offer new solution for patients with myopia and astigmatism

KE Eye Centers of Texas is the first in the Dallas-Fort Worth Metroplex to provide a new solution for patients with moderate to high levels of myopia and astigmatism in one simple procedure, following FDA approval of STAAR Surgical's Visian Toric ICL.

9 Nov 2018

Purdue researchers invent new smart drainage device to help glaucoma patients

Purdue University researchers have invented a new smart drainage device to help patients with glaucoma, a leading cause of blindness in the world, as they try to save their eyesight.

9 Nov 2018

Common glaucoma tests can underestimate severity of the condition

The most common tests for glaucoma can underestimate the severity of the condition by not detecting the presence of central vision loss, according to a new Columbia University study.

8 Nov 2018

Study could provide novel treatment strategy for potentially blinding problem

An enzyme known to help our liver get rid of ammonia also appears to be good at protecting our retina, scientists report.

8 Nov 2018

Genetic inhibition of SARM1 prevents axonal degeneration in nervous systems

Disarm Therapeutics, a biotechnology company creating a new class of disease-modifying therapeutics for patients with axonal degeneration, a central driver of neurological disease, today announced data demonstrating that genetic inhibition of SARM1 prevents axonal degeneration in the central, ocular and peripheral nervous systems.

5 Nov 2018

Researchers find a class of drug that could be promising treatment for uveitis

Ocular inflammation uveitis is a serious disease that can destroy eye tissue and cause irreversible blindness.

2 Nov 2018

Lab-created mini retinas allow researchers to understand retinal ganglion cell development

IUPUI biologists are growing 'mini retinas' in the lab from stem cells to mimic the growth of the human retina. The researchers hope to use the research to restore sight when critical connections between the eye and the brain are damaged.

25 Oct 2018

Potential new biomarkers may aid early detection of glaucoma

Researchers at Ruhr-Universität Bochum have identified new potential biomarkers that may facilitate early detection of glaucoma in patients. Moreover, they ascertained that the mutation of a certain gene in mice causes intraocular pressure elevation.

25 Oct 2018

Immunotherapy medicine found to be effective in treating uveitis

A team of researchers from the UCH CEU's Biomedical Sciences Institute has tested the efficiency of Bevacizumab, medicine used against cancer and in ophtalmology, to treat uveítis, thus stopping the inflammation from spreading.

19 Oct 2018

Fight for Sight chooses World Sight Day 2018 to announce funding for glaucoma research

Fight for Sight has chosen World Sight Day 2018 to announce funding for a research project that will develop personalized medicine for patients at risk of glaucoma from steroid use.

12 Oct 2018

Color-changing contact lens could help doctors to monitor eye disease medications

For all the good they do, eye drops and ointments have one major drawback: It's hard to tell how much of the medication is actually getting to the eye.

11 Oct 2018

Bioaxone Biosciences receives Fast-Track SBIR grant to assess potential of Rho Kinase 2 inhibitor

BioAxone BioSciences, Inc. announced today the receipt of a Fast-Track grant from the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, as part of the agency's Small Business Innovation Research Program.

27 Sep 2018

Your Vision Matters: How to Protect Your Eyesight

Dr. Neil Ebenezer from the charity Fight for Sight discusses the steps you can take to protect your eyesight into old age, and why research into ophthalmic diseases is desperately needed.

24 Sep 2018

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

GlaxoSmithKline plc and Innoviva, Inc. announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion today supporting the use of Trelegy Ellipta in a broader group of patients with moderate to severe chronic obstructive pulmonary disease and that labeling, if approved, will be updated to further reflect its effect on exacerbations of COPD.

21 Sep 2018

Multi-year study data shows impact of new soft contact lens to slow myopia progression in children

New four-year study data shows the significant impact of a pioneering contact lens management approach to slowing the progression of myopia (nearsightedness) in children, including those whose treatment begins later.

19 Sep 2018

Alcon expands its global support of eye care professionals through Alcon Experience Academy

Alcon, the global leader in eye care and a division of Novartis, is expanding its extensive, global support of eye care professionals through the unveiling of the Alcon Experience Academy.

18 Sep 2018

Eastenders actress supports awareness campaign on importance of eye tests

Leading eye research charity Fight for Sight has found that nearly three in ten British adults don’t follow the NHS recommendation to have an eye test every two years, and that the majority of this group (74%) say that it’s either because they can’t afford it or because they ‘can see fine’.

11 Sep 2018

Primary care providers could play major role in promoting vision care for older adults

A new poll suggests that primary care providers could play an important role in promoting vision care for adults age 50 and older, especially for those most in need of eye exams, and those most sensitive to the cost.

5 Sep 2018

Glaucoma News and Research

Latest Glaucoma News and Research

RetiPharma secures funding to develop new peptide drug for treating degenerative eye disorders

Chronic dry eye can slow reading rate and disrupt day to day tasks

KE Eye Centers offer new solution for patients with myopia and astigmatism

Purdue researchers invent new smart drainage device to help glaucoma patients

Common glaucoma tests can underestimate severity of the condition

Study could provide novel treatment strategy for potentially blinding problem

Genetic inhibition of SARM1 prevents axonal degeneration in nervous systems

Researchers find a class of drug that could be promising treatment for uveitis

Lab-created mini retinas allow researchers to understand retinal ganglion cell development

Potential new biomarkers may aid early detection of glaucoma

Immunotherapy medicine found to be effective in treating uveitis

Fight for Sight chooses World Sight Day 2018 to announce funding for glaucoma research

Color-changing contact lens could help doctors to monitor eye disease medications

Bioaxone Biosciences receives Fast-Track SBIR grant to assess potential of Rho Kinase 2 inhibitor

Your Vision Matters: How to Protect Your Eyesight

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

Multi-year study data shows impact of new soft contact lens to slow myopia progression in children

Alcon expands its global support of eye care professionals through Alcon Experience Academy

Eastenders actress supports awareness campaign on importance of eye tests

Primary care providers could play major role in promoting vision care for older adults

Innovation in neuroscience drug discovery - eBook eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Glaucoma News and Research

Latest Glaucoma News and Research

Innovation in neuroscience drug discovery - eBook eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in